Latest news

Clinical

Novartis Reports Positive Phase 1/2 Results for Del-Brax in FSHD

Novartis has reported positive topline results from the Phase 1/2 FORTITUDE study of delpacibart braxlosiran (del-brax), an investigational RNA-based...
Insights

Is Pharma Ready for the Age of Autonomous Work?

Executive Summary For years, pharmaceutical organizations have focused on automating tasks. From robotic process automation and workflow management tools to machine...
Manufacturing

Following Navacaprant’s disappointing late-stage results, Neumora will fire thirty-five percent of its employees

Neumora announced that its two studies evaluating navacaprant in MDD (Koastal-2 and Koastal-3) were not statistically significant on their...
Regulatory

FDA Approves Welireg-Keytruda Combination for Adjuvant Treatment of Clear Cell Renal Cell Carcinoma

Merck & Co. has received U.S. FDA approval for a combination of Welireg and Keytruda as an adjuvant treatment...
Clinical

Takeda’s Inhibitor Gets the Better of BMS’ Sotyktu in Phase 3 Psoriasis Battle

Takeda has outperformed Bristol Myers Squibb (BMS) in the...
Insights

Top 10 Forces Reshaping the Future of Life Sciences Operations

Executive Summary Life sciences operations are undergoing one of the...
Insights

Precision Medicine Moves From Vision to Reality

Executive Summary For decades, precision medicine was viewed as one of healthcare's most promising future concepts. The idea was simple yet...
Insights

Digital Pharma Manufacturing Is Finally Delivering on Its Promise

Executive Summary For more than two decades, pharmaceutical manufacturers have invested heavily in digital transformation initiatives. The vision was compelling. Connected production...
Insights

How Commercial Teams Are Using AI to Improve Launch Performance

Executive Summary Product launches have always been among the most critical moments in the pharmaceutical industry. A successful launch can establish...
Clinical

Sanofi Ends Phase 3 Trial of Riliprubart in CIDP After Interim Review

Sanofi has discontinued one of its phase 3 clinical...
Regulatory

Tofidence Receives FDA Approval for CRS and COVID-19 Treatment Expansion

Organon announced on Wednesday that the U.S. Food and...
Insights

The New Playbook for Pharmaceutical Growth

Executive Summary For decades, pharmaceutical growth followed a relatively predictable formula. Companies invested heavily in research and development, advanced promising assets...
Insights

Top 10 Operational Risks in Modern Clinical Trial Management

Executive Summary Clinical trial management has become significantly more complex over the past decade. Modern studies involve larger volumes of...
Commercial

Eli Lilly Secures Global Rights to AlzeCure Alzheimer’s Drug Candidate in Deal Worth Over $1 Billion

Eli Lilly has entered into a collaboration and out-licensing agreement with AlzeCure Pharma to acquire global rights to an...
Commercial

Roche’s Spark Joins Forces with SpliceBio for Innovative Inherited Retinal Disease Solutions

Roche's gene therapy arm, Spark, has made a significant...
Commercial

Evommune Seeks IPO to Advance Work on Immune Drug

It looks like biotech IPOs are about to become...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

Regulatory

Insights

Is Pharma Ready for the Age of Autonomous Work?

Executive Summary For years, pharmaceutical organizations have focused on automating...
Manufacturing

Following Navacaprant’s disappointing late-stage results, Neumora will fire thirty-five percent of its employees

Neumora announced that its two studies evaluating navacaprant in...
Regulatory

FDA Approves Welireg-Keytruda Combination for Adjuvant Treatment of Clear Cell Renal Cell Carcinoma

Merck & Co. has received U.S. FDA approval for...
Clinical

Caribou Gets CAR-T Boost Ahead of Phase 3 Trial

Caribou Biosciences has reported that its CAR-T cell therapy...

Research & Development

Market Access

Manufacturing

Novartis Names Texas as Site For RadioPharma Production Facility

Novartis is moving quickly to outline how radiopharmaceutical manufacturing...
Manufacturing

Cellares Raises $257 Million Series D to Expand Global Cell Therapy Manufacturing

Cellares has raised $257 million in a Series D...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Clinical

Novartis Reports Positive Phase 1/2 Results for Del-Brax in FSHD

Novartis has reported positive topline results from the Phase...
Editorial Team -